{"resourceType":"ValueSet","id":"high-low-codes-vs","text":{"status":"extensions","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Include these codes as defined in <a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\"><code>http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-H\">H</a></td><td>High</td><td>The result for a quantitative observation is above the upper limit of the reference range (as defined for the respective test procedure).<br/><br/>Synonym: Above high normal</td></tr><tr><td><a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-L\">L</a></td><td>Low</td><td>The result for a quantitative observation is below the lower limit of the reference range (as defined for the respective test procedure).<br/><br/>Synonym: Below low normal</td></tr><tr><td><a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-I\">I</a></td><td>Intermediate</td><td>Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with uncertain therapeutic effect. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\\_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2<br/><br/>\\[Note 1: Bacterial strains are categorized as intermediate by applying the appropriate breakpoints in a defined phenotypic test system.\\]<br/><br/>\\[Note 2: This class of susceptibility implies that an infection due to the isolate can be appropriately treated in body sites where the drugs are physiologically concentrated or when a high dosage of drug can be used.\\]<br/><br/>\\[Note 3: This class also indicates a &quot;buffer zone,&quot; to prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations.\\]<br/><br/>\\[Note 4: These breakpoints can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\\]</td></tr></table></li></ul></div>"},"url":"http://hl7.org/fhir/uv/genomics-reporting/ValueSet/high-low-codes-vs","version":"2.0.0","name":"HighLowCodesVS","title":"High Low codes","status":"active","date":"2022-05-09T16:53:07+00:00","publisher":"HL7 Clinical Genomics Working Group","contact":[{"name":"HL7 Clinical Genomics Working Group","telecom":[{"system":"url","value":"http://www.hl7.org/Special/committees/clingenomics"},{"system":"email","value":"cg@lists.HL7.org"}]}],"description":"This value set includes high/low codes for Observation Interpretations","jurisdiction":[{"coding":[{"system":"http://unstats.un.org/unsd/methods/m49/m49.htm","code":"001","display":"World"}]}],"compose":{"include":[{"system":"http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation","concept":[{"code":"H","display":"High"},{"code":"L","display":"Low"},{"code":"I","display":"Intermediate"}]}]}}